Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Triple-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VYD2311 for the Prevention of COVID-19 in Adults and Adolescents

NCT07298434 is registered in ClinicalTrials.gov with Invivyd, Inc. as lead sponsor.

NCT NCT07298434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07298434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Triple-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VYD2311 for the Prevention of COVID-19 in Adults and Adolescents
Lead sponsor
Invivyd, Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 8, 2026
Completion date
August 31, 2026
Enrollment
1,770 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19